# Agency Information Collection Activities; Submission for OMB Review; Comment Request; Pharmacy Billing Requirements
**ACTION:**
Notice.
**SUMMARY:**
The Department of Labor (DOL) is submitting the Office of Workers' Compensation Programs (OWCP) sponsored information collection request (ICR) titled, “Pharmacy Billing Requirements,” to the Office of Management and Budget (OMB) for review and approval for continued use in accordance with the Paperwork Reduction Act (PRA) of 1995 (44 U.S.C. 3501 et seq.).
**DATES:**
Submit comments on or before January 18, 2013.
**ADDRESSES:**
A copy of this ICR with applicable supporting documentation; including a description of the likely respondents, proposed frequency of response, and estimated total burden may be obtained from the RegInfo.gov Web site, *http://www.reginfo.gov/public/do/PRAMain* , on the day following publication of this notice or by contacting Michel Smyth by telephone at 202-693-4129 (this is not a toll-free number) or sending an email to *[email protected].*
Submit comments about this request to the Office of Information and Regulatory Affairs, Attn: OMB Desk Officer for DOL-OWCP, Office of Management and Budget, Room 10235, 725 17th Street NW., Washington, DC 20503, Fax: 202-395-6881 (this is not a toll-free number), email: *[email protected].*
**FOR FURTHER INFORMATION CONTACT:**
Contact Michel Smyth by telephone at 202-693-4129 (this is not a toll-free number) or by email at *[email protected].*
**Authority:**
44 U.S.C. 3507(a)(1)(D).
**SUPPLEMENTARY INFORMATION:**
The OWCP is the agency responsible for administration of the Federal Employees' Compensation Act (FECA), 5 U.S.C. 8101 *et seq.,* the Black Lung Benefits Act, 30 U.S.C. 901 *et seq.,* and the Energy Employees Occupational Illness Compensation Program Act of 2000, 42 U.S.C. 7384 *et seq.* All three of these statutes require the OWCP to pay for covered medical treatment provided to beneficiaries; this medical treatment can include medicinal drugs dispensed by pharmacies. In order to determine whether amounts billed for drugs are appropriate, the OWCP must receive the required data elements—including the name of the patient/beneficiary, the National Drug Code number of each drug prescribed, the quantity provided, the prescription number and the date the prescription was filled. The regulations implementing these statutes require the collection of information needed to enable the OWCP to determine whether bills for drugs submitted directly by pharmacies or as reimbursement requests submitted by claimants should be paid. *See* 20 CFR 10.801, 30.701, 725.701 and 725.705.
This information collection is subject to the PRA. A Federal agency generally cannot conduct or sponsor a collection of information, and the public is generally not required to respond to an information collection, unless it is approved by the OMB under the PRA and displays a currently valid OMB Control Number. In addition, notwithstanding any other provisions of law, no person shall generally be subject to penalty for failing to comply with a collection of information that does not display a valid Control Number. *See* 5 CFR 1320.5(a) and 1320.6. The DOL obtains OMB approval for this information collection under Control Number 1240-0050. The current approval is scheduled to expire on December 31, 2012; however, it should be noted that existing information collection requirements submitted to the OMB receive a month-to-month extension while they undergo review. For additional information, see the related notice published in the *Federal Register* on September 17, 2012.
Interested parties are encouraged to send comments to the OMB, Office of Information and Regulatory Affairs at the address shown in the *ADDRESSES* section within 30 days of publication of this notice in the *Federal Register* . In order to help ensure appropriate consideration, comments should mention OMB Control Number 1250-0040. The OMB is particularly interested in comments that:
• Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;
• Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;
• Enhance the quality, utility, and clarity of the information to be collected; and
• Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses.
*Agency:* DOL-OWCP.
*Title of Collection:* Pharmacy Billing Requirements.
*OMB Control Number:* 1240-0050.
*Affected Public:* Individuals or households and private sector—businesses or other for-profits and not-for-profit institutions.
*Total Estimated Number of Respondents:* 4128.
*Total Estimated Number of Responses:* 1,498,532.
*Total Estimated Annual Burden Hours:* 26,917.
*Total Estimated Annual Other Costs Burden:* $0.
Dated: December 12, 2012.
Michel Smyth,
Departmental Clearance Officer.